Joanne Barnes

pharmacy

H指数:35

被引数:6,602

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Consumer Views on the Role of the Natural Health Products (NHPs) Industry in Pharmacovigilance for NHPs: A Qualitative Study in New Zealand

消费者对天然健康产品（NHPs）行业在NHPs药物警戒中作用的看法：一项在新西兰进行的定性研究

Drug Safety

IF3.8

2026-10-020

OAAI

Assessing Natural Health Product-Drug Interactions and Coding Feasibility: Analysis of a New Zealand General Population Dataset from an Online Market Research Panel

评估天然健康产品-药物相互作用及编码可行性的分析：来自新西兰一般人群在线市场研究面板的数据

Drug Safety

IF3.8

2026-05-090

OAAI

Pharmacovigilance Regulatory Requirements for the Natural Health Products (NHPs) Industry in World Health Organization-Defined High Health Expenditure Countries (2020): A Scoping Review

世界卫生组织定义的高医疗支出国家中天然健康产品（NHPs）行业的药物警戒监管要求（2020）：一项范围综述

Drug Safety

IF3.8

2026-04-280

PRE

A Scoping Review of Published Literature on the Contributions of the Natural Health Products (NHPs) Industry to Pharmacovigilance for NHPs

天然健康产品（NHPs）行业对天然健康产品（NHPs）药物警戒贡献的已发表文献范围综述

Drug Safety

IF3.8

2025-08-080

OAAI

Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial (vol 23, 1760, 2023)

BMC PUBLIC HEALTH

IF3.6

2025-01-220

OAAI

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

2010 2020年，厄洛替尼和吉非替尼治疗晚期表皮生长因子受体突变非鳞状非小细胞肺癌: 全国全患者人群回顾性队列研究

JMIR CANCER

IF2.7

2025-01-010

OAAI

BMC PUBLIC HEALTH

IF3.6

2023-09-111

OAAI

Prevalence of Use of Traditional, Complementary and Alternative Medicine by the General Population: A Systematic Review of National Studies Published from 2010 to 2019

DRUG SAFETY

IF3.8

2022-07-0553

OAAI

Study of Natural Products Adverse Reactions (SONAR) in Adults with Mental Health Conditions: A Cross-Sectional Study

DRUG SAFETY

IF3.8

2021-07-282

PREAI

Cytisine versus varenicline for smoking cessation in New Zealand indigenous Maori: a randomized controlled trial

ADDICTION

IF5.3

2021-05-0448

OAAI

Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand

DRUG SAFETY

IF3.8

2020-09-256

PREAI

Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand

DRUG SAFETY

IF3.8

2020-06-281

PREAI

The International Society of Pharmacovigilance (ISoP) Special Interest Group on Herbal and Traditional Medicines: Towards Progress in Pharmacovigilance for Herbal and Traditional Medicines and Other Natural Health Products

DRUG SAFETY

IF3.8

2020-04-2311

OAAI

Hypnotherapy for smoking cessation

催眠治疗戒烟

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2019-06-1437

OAAI

An Update on ISoP Special Interest Groups (SIGs)

DRUG SAFETY

IF3.8

2017-10-042

OAAI

Getting cytisine licensed for use world-wide: a call to action

ADDICTION

IF5.3

2016-07-1731

OAAI

Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2016-04-1241

PREAI

Dietary supplements for dysmenorrhoea

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2016-03-2249

OAAI

Cytisine versus Nicotine for Smoking Cessation

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2014-12-18172

OAAI

Pharmacovigilance of Herbal Medicines The Potential Contributions of Ethnobotanical and Ethnopharmacological Studies

DRUG SAFETY

IF3.8

2012-12-0832

PREAI

Joanne Barnes

个人简介

教育背景

工作经历

荣誉奖项

研究方向